Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/28884
Title: No correlation between lymphocyte pharmacodynamics and autoimmune adverse events following alemtuzumab treatment in patients with relapsing-remitting multiple sclerosis
Authors: Wiendl, H.
Brandes, D.
Carraro, M.
Comi, G.
Mao-Draayer, Y.
Izquierdo, G.
Kim, H. -J.
Meuth, S.
Pardo, G.
Sharrack, B.
Tornatore, C.
Ziemssen, T.
Jacobs, Andre
Chung, L.
Daizadeh, N.
Van Wijmeersch, Bart 
Issue Date: 2018
Publisher: SAGE PUBLICATIONS LTD
Source: MULTIPLE SCLEROSIS JOURNAL, 24(2), p. 468-469
Notes: [Wiendl, H.; Meuth, S.] Univ Munster, Munster, Germany. [Brandes, D.] Hope MS Ctr, Knoxville, TN USA. [Carraro, M.] Novant Hlth, Charlotte, NC USA. [Comi, G.] Univ Vita Salute San Raffaele, Milan, Italy. [Mao-Draayer, Y.] Univ Michigan, Sch Med, Ann Arbor, MI USA. [Izquierdo, G.] Virgen Macarena Univ Hosp, Seville, Spain. [Kim, H. -J.] Natl Canc Ctr, Res Inst & Hosp, Goyang, South Korea. [Pardo, G.] Oklahoma Med Res Fdn, OMRF Multiple Sclerosis Ctr Excellence, 825 NE 13th St, Oklahoma City, OK 73104 USA. [Sharrack, B.] Sheffield Teaching Hosp NHS Fdn Trust, Sheffield, S Yorkshire, England. [Tornatore, C.] Georgetown Univ, Med Ctr, Washington, DC 20007 USA. [Ziemssen, T.] Carl Gustav Carus Univ Hosp, Ctr Clin Neurosci, Dresden, Germany. [Jacobs, A.; Chung, L.; Daizadeh, N.] Sanofi, Cambridge, MA USA. [Van Wijmeersch, B.] Hasselt Univ, Rehabil & MS Ctr Overpelt, BIOMED, Hasselt, Belgium.
Document URI: http://hdl.handle.net/1942/28884
ISSN: 1352-4585
e-ISSN: 1477-0970
ISI #: 000446861401230
Category: M
Type: Journal Contribution
Appears in Collections:Research publications

Files in This Item:
File Description SizeFormat 
Poster Session 2.pdf
  Restricted Access
Published version82.59 kBAdobe PDFView/Open    Request a copy
Show full item record

Page view(s)

6
checked on Feb 16, 2021

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.